Browndove Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 6.16 M
as on 16-11-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
as on 16-11-2024
- Revenue -16.57%
(FY 2023)
- Profit -171.74%
(FY 2023)
- Ebitda -231.91%
(FY 2023)
- Net Worth -149.72%
(FY 2023)
- Total Assets -30.75%
(FY 2023)
About Browndove Formulations
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 6.16 M.
The company currently has active open charges totaling ₹3.50 M.
Krishnaswamy Gopalaswamy and Linganna Rajanna serve as directors at the Company.
- CIN/LLPIN
U33110KA2018PTC114635
- Company No.
114635
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2018
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Browndove Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnaswamy Gopalaswamy  | Director | 10-Jul-2018 | Current |
| Linganna Rajanna | Director | 10-Jul-2018 | Current |
Financial Performance and Corporate Structure Insights of Browndove Formulations.
Browndove Formulations Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.57% decrease. The company also saw a substantial fall in profitability, with a 171.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 149.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Browndove Formulations?
In 2023, Browndove Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Browndove Healthcare Private LimitedActive 24 years 4 monthsKrishnaswamy Gopalaswamy and Linganna Rajanna are mutual person
Ibex Engineering Private LimitedActive 23 years 8 monthsKrishnaswamy Gopalaswamy is a mutual person
- Hcm Ibex Engineering Private LimitedActive 18 years 6 months
Krishnaswamy Gopalaswamy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka Bank Ltd. Creation Date: 23 Nov 2020 | ₹0.50 M | Open |
Karnataka Bank Ltd. Creation Date: 13 Mar 2019 | ₹3.00 M | Open |
How Many Employees Work at Browndove Formulations?
Unlock and access historical data on people associated with Browndove Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Browndove Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Browndove Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
